Most Read Articles
6 days ago
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.
05 May 2015

Probiotics are continuously gaining in popularity, but advice on the right type and the correct way to take them is as important as ever, says pharmacist Seema Rambisheswar.

28 Dec 2017
Varenicline, while effective for smoking cessation, appears to significantly elevate the risk of cardiovascular hospitalization and emergency department visits, particularly for new users, a recent study shows.
29 Nov 2017
Younger children appear to be more likely to experience behavioural side effects of antiepileptic drugs (AEDs), with the likelihood increasing if children with epilepsy have baseline hyperactivity/impulsivity, a retrospective study has found.

Bisphosphonate ‘holiday’ tied to increased fracture risk

Roshini Claire Anthony
10 Nov 2017

Women who temporarily or permanently stop taking bisphosphonates (drug holiday) for an extended period of time may have an increased risk of hip fractures, findings from a recent population-based study revealed.

“[A] bisphosphonate drug holiday greater than 2 years was associated with a significantly increased risk for hip fracture of up to 39 percent compared with continued bisphosphonate use,” said study lead author Professor Jeffrey Curtis who presented the findings at the annual meeting of the ACR/ARHP* held in San Diego, California, US, on behalf of himself and his fellow investigators from the University of Alabama at Birmingham, Alabama, US.

Compared with current users (crude incidence rate, 9.6 per 1,000 person-years), women who had ceased bisphosphonate therapy for more than 2 and up to 3 years had the highest rate of fracture incidence (crude incidence rate, 15.7 per 1,000 person-years; adjusted hazard ratio [adjHR], 1.39). [ACR/ARHP 2017, abstract 828]

Women who had ceased bisphosphonate therapy for >0 to ≤3 months, >3 months to ≤1 year, and >1 to ≤2 years also had an increased risk of hip fracture (adjHR, 1.29, 1.12, and 1.21, respectively; crude incidence rate, 13.1, 12.0, and 13.3 per 1,000 person-years, respectively).

Using Medicare data from 2006 to 2014, researchers identified 156,236 women (mean age, 78.5 years) who were long-term users of bisphosphonate therapy and were ≥80 percent treatment-adherent for ≥3 years at baseline. Patients who used other bone therapies such as denosumab, oestrogen, calcitonin, or teriparatide were excluded.

Over a median 2.1-year follow-up period, 40.1 percent (n=62,676) of patients ceased bisphosphonate therapy for ≥6 months, 12.7 percent (n=7,947) of whom later restarted bisphosphonate therapy. There were 3,745 hip fractures reported during the follow-up period.

Hip fracture incidence was lowest among women currently on bisphosphonate therapy and increased with longer duration of drug holiday.

“Given FDA** warnings, drug holidays [temporary or permanent discontinuation] of bisphosphonates after long-term [3–5 years] continuous therapy is becoming increasingly common in the US,” said Curtis and colleagues.

“Our goal was to evaluate the risk of discontinuing therapy based on the length of the holiday, controlling for any possibly confounding factors, such as race, median income, rural or urban location, DXA scores, or comorbidities,” said Curtis.

“While the notion of a drug holiday has become commonplace in osteoporosis management, there’s a dearth of evidence on when we should consider restarting bisphosphonate therapy. The study’s findings may provide useful evidence to help guide rheumatologists as they plan long-term therapy for their patients dealing with low bone mass,” he added.  

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
6 days ago
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.
05 May 2015

Probiotics are continuously gaining in popularity, but advice on the right type and the correct way to take them is as important as ever, says pharmacist Seema Rambisheswar.

28 Dec 2017
Varenicline, while effective for smoking cessation, appears to significantly elevate the risk of cardiovascular hospitalization and emergency department visits, particularly for new users, a recent study shows.
29 Nov 2017
Younger children appear to be more likely to experience behavioural side effects of antiepileptic drugs (AEDs), with the likelihood increasing if children with epilepsy have baseline hyperactivity/impulsivity, a retrospective study has found.